Forward Pharma A/S (FWPAY) Stock Price, News & Analysis

Company Overview

Forward Pharma A/S is a biopharmaceutical company, which engages in the research and development of medicinal treatment for inflammatory and neurological indications. It focuses on the immunomodulatory compound dimethyl fumarate and its derivatives. The company was founded by Florian Schönharting on July 2005 and is headquartered in Copenhagen, Denmark.

Key Stats

• Today's Range: $300.00 to $400.00
• 50-Day Range: $2.00 to $800.00
• 52-Week Range: $1.43 to $5.33
• Volume: 11 shs
• Average Volume: 7 shs
• Market Capitalization: $6 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

FWPAY Stock Analysis - Frequently Asked Questions

When did Forward Pharma A/S's stock split?

Shares of Forward Pharma A/S reverse split before market open on Thursday, June 8th 2023. The 1-285.7139 reverse split was announced on Thursday, June 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Thursday, June 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

Company Calendar

• Today: 5/11/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: Pharmaceutical preparations
• Sub-Industry: N/A
• Current Symbol: NASDAQ:FWPAY
• CIK: 1604924
• Web: N/A
• Phone: (453) 344-4242
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 20,000
• Free Float: 7,000
• Market Cap: $6 million
• Optionable: Not Optionable
• Beta: -42.67